From colorless to pink: Structural insights into vitamin B12-induced color change in monoclonal antibodies
Background: Monoclonal antibodies (mAbs) are typically colorless; however, the pink coloration observed during production raises quality concerns. This study investigated the mechanism linking this color change to Vitamin B12 (VB12), which converts to hydroxycobalamin (OH-Cbl) under light and binds...
Saved in:
| Published in | Medicine in drug discovery Vol. 28; p. 100224 |
|---|---|
| Main Authors | , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Elsevier
01.12.2025
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Background: Monoclonal antibodies (mAbs) are typically colorless; however, the pink coloration observed during production raises quality concerns. This study investigated the mechanism linking this color change to Vitamin B12 (VB12), which converts to hydroxycobalamin (OH-Cbl) under light and binds covalently to cysteine residues in antibodies via cobalt-sulfur bonds. Methods: Three batches of IgG1 antibodies (SP1, SP2, and NL)—were expressed in CHO cells, exposed to light, and purified. Binding interactions were analyzed using HPLC, RP-UPLC/MS, SDS-PAGE, and hydrophobic interaction chromatography (HIC). Peptide mapping and 3D structural modeling using protenix and autodock vina software identified the binding sites and spatial requirements. Results: OH-Cbl covalently binds to five cysteine residues: L_Csy138 and L_Csy218 (light chain) and H_Csy22, H_Csy96, and H_Csy323 (heavy chain). SP2 exhibited a higher VB12 content (molar ratio 1:5.71 vs. 1:9.74 in SP1) and increased hydrophobicity, confirming covalent attachment. Structural modeling revealed large protein pockets around these cysteines, accommodating VB12′s bulky structure. Peptide analysis revealed distinct UV absorption at 360 nm for SP2, while SDS-PAGE indicated slight molecular weight differences. Conclusion: The pink coloration arises from the light-induced conversion of VB12 to OH-Cbl, which binds covalently to specific cysteine residues, facilitated by spatially permissive protein pockets. Controlling the light exposure during production can mitigate this phenomenon. This study elucidates the structural basis of antibody-VB12 interactions, offering critical insights for optimizing mAb quality control. |
|---|---|
| AbstractList | Background: Monoclonal antibodies (mAbs) are typically colorless; however, the pink coloration observed during production raises quality concerns. This study investigated the mechanism linking this color change to Vitamin B12 (VB12), which converts to hydroxycobalamin (OH-Cbl) under light and binds covalently to cysteine residues in antibodies via cobalt-sulfur bonds. Methods: Three batches of IgG1 antibodies (SP1, SP2, and NL)—were expressed in CHO cells, exposed to light, and purified. Binding interactions were analyzed using HPLC, RP-UPLC/MS, SDS-PAGE, and hydrophobic interaction chromatography (HIC). Peptide mapping and 3D structural modeling using protenix and autodock vina software identified the binding sites and spatial requirements. Results: OH-Cbl covalently binds to five cysteine residues: L_Csy138 and L_Csy218 (light chain) and H_Csy22, H_Csy96, and H_Csy323 (heavy chain). SP2 exhibited a higher VB12 content (molar ratio 1:5.71 vs. 1:9.74 in SP1) and increased hydrophobicity, confirming covalent attachment. Structural modeling revealed large protein pockets around these cysteines, accommodating VB12′s bulky structure. Peptide analysis revealed distinct UV absorption at 360 nm for SP2, while SDS-PAGE indicated slight molecular weight differences. Conclusion: The pink coloration arises from the light-induced conversion of VB12 to OH-Cbl, which binds covalently to specific cysteine residues, facilitated by spatially permissive protein pockets. Controlling the light exposure during production can mitigate this phenomenon. This study elucidates the structural basis of antibody-VB12 interactions, offering critical insights for optimizing mAb quality control. |
| ArticleNumber | 100224 |
| Author | Fu, Li-dan Li, Yuan Tong, Xin-yue Lin, Han-bin Deng, Wen-hui Wang, Chun-he He, Kai-feng Xing, Na Cui, Hao-dong Liu, Guo-jian Chaurembo, Abdallah Iddy |
| Author_xml | – sequence: 1 givenname: Kai-feng surname: He fullname: He, Kai-feng – sequence: 2 givenname: Hao-dong surname: Cui fullname: Cui, Hao-dong – sequence: 3 givenname: Wen-hui surname: Deng fullname: Deng, Wen-hui – sequence: 4 givenname: Na surname: Xing fullname: Xing, Na – sequence: 5 givenname: Guo-jian surname: Liu fullname: Liu, Guo-jian – sequence: 6 givenname: Abdallah Iddy orcidid: 0009-0002-0511-8481 surname: Chaurembo fullname: Chaurembo, Abdallah Iddy – sequence: 7 givenname: Li-dan surname: Fu fullname: Fu, Li-dan – sequence: 8 givenname: Yuan surname: Li fullname: Li, Yuan – sequence: 9 givenname: Xin-yue surname: Tong fullname: Tong, Xin-yue – sequence: 10 givenname: Han-bin surname: Lin fullname: Lin, Han-bin – sequence: 11 givenname: Chun-he surname: Wang fullname: Wang, Chun-he |
| BookMark | eNpNkMtOwzAURC1UJAr0D1j4B1L8zIMdVBQqVWIBrK0b22kdEruyUyT-npQgxOqO5s6cxVyimQ_eInRDyZISmt-2y94aZ8ySESZHizAmztCcyYpkpCrz2T99gRYptWTMSEppzueoXcfQYx26EDubEh4CPjj_cYdfh3jUwzFCh51Pbrcf0ijG96cboHceP1CWOW-O2pqpj_Ue_M6OKdwHH3QX_FgGP7g6GGfTNTpvoEt28Xuv0Pv68W31nG1fnjar-22mWSlEVgldyUILIquC6oJLqRm30goOpATCGigrIxrgOZM5MTaXojSGNbWpqeRM8iu0mbgmQKsO0fUQv1QAp36MEHcK4uB0Z1UhRoYpTG0hF4yZssq5sQQsgKaSkJElJpaOIaVomz8eJeo0v2rVNL86za-m-fk3JGp8hA |
| Cites_doi | 10.3390/biom10101429 10.1155/2017/8475125 10.1016/bs.vh.2022.01.012 10.1038/s41401-021-00737-x 10.1073/pnas.1616408114 10.3390/molecules28031447 10.1016/j.addr.2006.03.011 10.1016/j.jphotobiol.2013.03.001 10.1002/bit.26511 10.1016/bs.mie.2021.12.012 10.4161/mabs.28257 10.1021/acs.jpcb.2c04525 10.3390/molecules15053228 10.1038/s42255-021-00465-w 10.3390/biomedicines10071757 10.1016/0009-8981(83)90090-6 10.4161/mabs.25921 10.4161/mabs.2.5.12645 10.1136/bmjopen-2019-033687 10.52601/bpr.2023.230002 10.1177/03795721241228631 10.1016/j.biochi.2020.06.014 10.1002/bit.22848 10.1002/bit.27790 10.1016/bs.vh.2022.02.003 10.1002/btpr.1772 10.1038/s42255-021-00486-5 10.1093/nutrit/nuu011 10.1016/j.str.2024.04.014 |
| ContentType | Journal Article |
| DBID | AAYXX CITATION DOA |
| DOI | 10.1016/j.medidd.2025.100224 |
| DatabaseName | CrossRef DOAJ Open Access Full Text |
| DatabaseTitle | CrossRef |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Open Access Full Text url: https://www.doaj.org/ sourceTypes: Open Website |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 2590-0986 |
| ExternalDocumentID | oai_doaj_org_article_74256d7dbea6422d8963de0aeaac1500 10_1016_j_medidd_2025_100224 |
| GroupedDBID | 0R~ AAEDW AALRI AAXUO AAYWO AAYXX ACVFH ADCNI ADVLN AEUPX AEXQZ AFJKZ AFPUW AIGII AITUG AKBMS AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP CITATION EBS EJD FDB GROUPED_DOAJ M41 M~E OK1 ROL |
| ID | FETCH-LOGICAL-c2844-94c957c405971c7355c23e5e43a08a02fa89d4fa362560de6548dd2fbdb153253 |
| IEDL.DBID | DOA |
| ISSN | 2590-0986 |
| IngestDate | Wed Aug 27 00:47:32 EDT 2025 Wed Aug 27 16:39:13 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c2844-94c957c405971c7355c23e5e43a08a02fa89d4fa362560de6548dd2fbdb153253 |
| ORCID | 0009-0002-0511-8481 |
| OpenAccessLink | https://doaj.org/article/74256d7dbea6422d8963de0aeaac1500 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_74256d7dbea6422d8963de0aeaac1500 crossref_primary_10_1016_j_medidd_2025_100224 |
| PublicationCentury | 2000 |
| PublicationDate | 2025-12-00 2025-12-01 |
| PublicationDateYYYYMMDD | 2025-12-01 |
| PublicationDate_xml | – month: 12 year: 2025 text: 2025-12-00 |
| PublicationDecade | 2020 |
| PublicationTitle | Medicine in drug discovery |
| PublicationYear | 2025 |
| Publisher | Elsevier |
| Publisher_xml | – name: Elsevier |
| References | Mascarenhas (10.1016/j.medidd.2025.100224_b0155) 2022; 668 Juzeniene (10.1016/j.medidd.2025.100224_b0080) 2013; 122 Wang (10.1016/j.medidd.2025.100224_b0100) 2018; 3 Liu (10.1016/j.medidd.2025.100224_b0110) 2023; 9 Kennedy (10.1016/j.medidd.2025.100224_b0115) 2020; 10 10.1016/j.medidd.2025.100224_b0005 Léveillard (10.1016/j.medidd.2025.100224_b0130) 2017; 2017 van Kapel (10.1016/j.medidd.2025.100224_b0145) 1983; 131 Derfus (10.1016/j.medidd.2025.100224_b0030) 2014; 6 Sullivan (10.1016/j.medidd.2025.100224_b0160) 2021; 3 Liu (10.1016/j.medidd.2025.100224_b0040) 2010; 2 Kao (10.1016/j.medidd.2025.100224_b0125) 2010; 107 Cheng (10.1016/j.medidd.2025.100224_b0140) 2022; 43 Vidal-Alaball (10.1016/j.medidd.2025.100224_b0090) 2005; 20 Vašková (10.1016/j.medidd.2025.100224_b0120) 2023; 28 Martínez Felices (10.1016/j.medidd.2025.100224_b0150) 2024; 32 Vijayasankaran (10.1016/j.medidd.2025.100224_b0085) 2013; 29 Skolnick (10.1016/j.medidd.2025.100224_b0135) 2022; 126 Sanz-Cuesta (10.1016/j.medidd.2025.100224_b0095) 2020; 10 Jain (10.1016/j.medidd.2025.100224_b0015) 2017; 114 Prentice (10.1016/j.medidd.2025.100224_b0045) 2013; 5 Ghosh (10.1016/j.medidd.2025.100224_b0075) 2022; 119 Hasan (10.1016/j.medidd.2025.100224_b0105) 2022; 10 Du (10.1016/j.medidd.2025.100224_b0050) 2018; 115 Ghergurovich (10.1016/j.medidd.2025.100224_b0165) 2021; 3 10.1016/j.medidd.2025.100224_b0035 10.1016/j.medidd.2025.100224_b0010 10.1016/j.medidd.2025.100224_b0175 Liu (10.1016/j.medidd.2025.100224_b0020) 2015; 21 10.1016/j.medidd.2025.100224_b0055 Sokolovskaya (10.1016/j.medidd.2025.100224_b0170) 2021; 183 Ren (10.1016/j.medidd.2025.100224_b0180) 2021; 118 Daugherty (10.1016/j.medidd.2025.100224_b0025) 2006; 58 Gille (10.1016/j.medidd.2025.100224_b0070) 2015; 73 Randaccio (10.1016/j.medidd.2025.100224_b0065) 2010; 15 Green (10.1016/j.medidd.2025.100224_b0060) 2022; 119 |
| References_xml | – volume: 10 start-page: 1429 issue: 10 year: 2020 ident: 10.1016/j.medidd.2025.100224_b0115 article-title: Role of glutathione in cancer: from mechanisms to therapies publication-title: Biomolecules doi: 10.3390/biom10101429 – volume: 2017 year: 2017 ident: 10.1016/j.medidd.2025.100224_b0130 article-title: Cell signaling with extracellular thioredoxin and thioredoxin-like proteins: insight into their mechanisms of action publication-title: Oxid Med Cell Longev doi: 10.1155/2017/8475125 – volume: 119 start-page: 185 year: 2022 ident: 10.1016/j.medidd.2025.100224_b0075 article-title: Photolytic properties of B12-dependent enzymes: a theoretical perspective publication-title: Vitam Horm doi: 10.1016/bs.vh.2022.01.012 – volume: 43 start-page: 1046 issue: 4 year: 2022 ident: 10.1016/j.medidd.2025.100224_b0140 article-title: Okicamelliaside targets the N-terminal chaperone pocket of HSP90 disrupts the chaperone protein interaction of HSP90-CDC37 and exerts antitumor activity publication-title: Acta Pharmacol Sin doi: 10.1038/s41401-021-00737-x – volume: 114 start-page: 944 issue: 5 year: 2017 ident: 10.1016/j.medidd.2025.100224_b0015 article-title: Biophysical properties of the clinical-stage antibody landscape publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1616408114 – volume: 28 start-page: 1447 issue: 3 year: 2023 ident: 10.1016/j.medidd.2025.100224_b0120 article-title: Glutathione-related enzymes and proteins: a review publication-title: Molecules doi: 10.3390/molecules28031447 – volume: 58 start-page: 686 issue: 5–6 year: 2006 ident: 10.1016/j.medidd.2025.100224_b0025 article-title: Formulation and delivery issues for monoclonal antibody therapeutics publication-title: Adv Drug Deliv Rev doi: 10.1016/j.addr.2006.03.011 – volume: 122 start-page: 7 year: 2013 ident: 10.1016/j.medidd.2025.100224_b0080 article-title: Photodegradation of cobalamins in aqueous solutions and in human blood publication-title: J Photochem Photobiol B doi: 10.1016/j.jphotobiol.2013.03.001 – volume: 115 start-page: 900 issue: 4 year: 2018 ident: 10.1016/j.medidd.2025.100224_b0050 article-title: Vitamin B12 association with mAbs: Mechanism and potential mitigation strategies publication-title: Biotechnol Bioeng doi: 10.1002/bit.26511 – ident: 10.1016/j.medidd.2025.100224_b0010 – ident: 10.1016/j.medidd.2025.100224_b0035 – volume: 668 start-page: 309 year: 2022 ident: 10.1016/j.medidd.2025.100224_b0155 article-title: Human B12-dependent enzymes: methionine synthase and Methylmalonyl-CoA mutase publication-title: Methods Enzymol doi: 10.1016/bs.mie.2021.12.012 – volume: 6 start-page: 679 issue: 3 year: 2014 ident: 10.1016/j.medidd.2025.100224_b0030 article-title: Red colored IgG4 caused by vitamin B12 from cell culture media combined with disulfide reduction at harvest publication-title: MAbs doi: 10.4161/mabs.28257 – volume: 126 start-page: 6853 issue: 36 year: 2022 ident: 10.1016/j.medidd.2025.100224_b0135 article-title: Implications of the essential role of small molecule ligand binding pockets in protein-protein interactions publication-title: J Phys Chem B doi: 10.1021/acs.jpcb.2c04525 – volume: 15 start-page: 3228 issue: 5 year: 2010 ident: 10.1016/j.medidd.2025.100224_b0065 article-title: Vitamin B12: unique metalorganic compounds and the most complex vitamins publication-title: Molecules doi: 10.3390/molecules15053228 – volume: 3 start-page: 1512 issue: 11 year: 2021 ident: 10.1016/j.medidd.2025.100224_b0165 article-title: Methionine synthase supports tumour tetrahydrofolate pools publication-title: Nat Metab doi: 10.1038/s42255-021-00465-w – volume: 10 start-page: 1757 issue: 7 year: 2022 ident: 10.1016/j.medidd.2025.100224_b0105 article-title: The thioredoxin system of mammalian cells and its modulators publication-title: Biomedicines doi: 10.3390/biomedicines10071757 – volume: 131 start-page: 211 issue: 3 year: 1983 ident: 10.1016/j.medidd.2025.100224_b0145 article-title: Improved distribution analysis of cobalamins and cobalamin analogues in human plasma in which the use of thiol-blocking agents is a prerequisite publication-title: Clin Chim Acta doi: 10.1016/0009-8981(83)90090-6 – ident: 10.1016/j.medidd.2025.100224_b0175 – volume: 5 start-page: 974 issue: 6 year: 2013 ident: 10.1016/j.medidd.2025.100224_b0045 article-title: Hydroxocobalamin association during cell culture results in pink therapeutic proteins publication-title: MAbs doi: 10.4161/mabs.25921 – volume: 2 start-page: 480 issue: 5 year: 2010 ident: 10.1016/j.medidd.2025.100224_b0040 article-title: Recovery and purification process development for monoclonal antibody production publication-title: MAbs doi: 10.4161/mabs.2.5.12645 – volume: 10 issue: 8 year: 2020 ident: 10.1016/j.medidd.2025.100224_b0095 article-title: Oral versus intramuscular administration of vitamin B12 for vitamin B12 deficiency in primary care: a pragmatic, randomised, non-inferiority clinical trial (OB12) publication-title: BMJ Open doi: 10.1136/bmjopen-2019-033687 – volume: 9 start-page: 26 issue: 1 year: 2023 ident: 10.1016/j.medidd.2025.100224_b0110 article-title: Antioxidant activity of the thioredoxin system publication-title: Biophys Rep doi: 10.52601/bpr.2023.230002 – volume: 20 issue: 3 year: 2005 ident: 10.1016/j.medidd.2025.100224_b0090 article-title: Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency publication-title: Cochrane Database Syst Rev – ident: 10.1016/j.medidd.2025.100224_b0055 doi: 10.1177/03795721241228631 – volume: 183 start-page: 35 year: 2021 ident: 10.1016/j.medidd.2025.100224_b0170 article-title: Naturally occurring cobalamin (B12) analogs can function as cofactors for human methylmalonyl-CoA mutase publication-title: Biochimie doi: 10.1016/j.biochi.2020.06.014 – volume: 107 start-page: 622 issue: 4 year: 2010 ident: 10.1016/j.medidd.2025.100224_b0125 article-title: Mechanism of antibody reduction in cell culture production processes publication-title: Biotechnol Bioeng doi: 10.1002/bit.22848 – volume: 118 start-page: 2829 issue: 8 year: 2021 ident: 10.1016/j.medidd.2025.100224_b0180 article-title: Antibody disulfide bond reduction and recovery during biopharmaceutical process development-a review publication-title: Biotechnol Bioeng doi: 10.1002/bit.27790 – volume: 3 issue: 3 year: 2018 ident: 10.1016/j.medidd.2025.100224_b0100 article-title: Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency publication-title: Cochrane Database Syst Rev – volume: 119 start-page: 405 year: 2022 ident: 10.1016/j.medidd.2025.100224_b0060 article-title: Vitamin B12 deficiency publication-title: Vitam Horm doi: 10.1016/bs.vh.2022.02.003 – volume: 29 start-page: 1270 issue: 5 year: 2013 ident: 10.1016/j.medidd.2025.100224_b0085 article-title: Effect of cell culture medium components on color of formulated monoclonal antibody drug substance publication-title: Biotechnol Prog doi: 10.1002/btpr.1772 – ident: 10.1016/j.medidd.2025.100224_b0005 – volume: 21 start-page: 559 issue: 7 year: 2015 ident: 10.1016/j.medidd.2025.100224_b0020 article-title: Intravenous versus subcutaneous anti-TNF-alpha agents for crohn's disease: a comparison of effectiveness and safety publication-title: J Manag Care Spec Pharm – volume: 3 start-page: 1500 issue: 11 year: 2021 ident: 10.1016/j.medidd.2025.100224_b0160 article-title: Methionine synthase is essential for cancer cell proliferation in physiological folate environments publication-title: Nat Metab doi: 10.1038/s42255-021-00486-5 – volume: 73 start-page: 106 issue: 2 year: 2015 ident: 10.1016/j.medidd.2025.100224_b0070 article-title: Vitamin B12 in meat and dairy products publication-title: Nutr Rev doi: 10.1093/nutrit/nuu011 – volume: 32 start-page: 1165 issue: 8 year: 2024 ident: 10.1016/j.medidd.2025.100224_b0150 article-title: Cobalamin decyanation by the membrane transporter BtuM publication-title: Structure doi: 10.1016/j.str.2024.04.014 |
| SSID | ssj0002511163 |
| Score | 2.3105412 |
| Snippet | Background: Monoclonal antibodies (mAbs) are typically colorless; however, the pink coloration observed during production raises quality concerns. This study... |
| SourceID | doaj crossref |
| SourceType | Open Website Index Database |
| StartPage | 100224 |
| SubjectTerms | Antibody color Cysteine Protein pocket Vitamin B12 |
| Title | From colorless to pink: Structural insights into vitamin B12-induced color change in monoclonal antibodies |
| URI | https://doaj.org/article/74256d7dbea6422d8963de0aeaac1500 |
| Volume | 28 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV07a8MwEBYlU5fSJ01faCiZImrLUmx3a0pCKKQEmkA2o5chobFDHQpZ-tt7ZyVNOnXpYixZNuJO1n2H7r4j5F4HNg1tFLGOjAQT0GSJ6uRM5lqGLtaS1xnew9fOYCJepnK6V-oLY8I8PbAX3AO4brJjY6udAqjMbQIrxrpAOaUMgJnaWwebt-dM4R6MwBmQxjZXrg7owsNqi-SgXNbEo1z8skV7lP21bekfk6MNKKRPfjIn5MAVp6Q18qzS6zYd75KkqjZt0dGOb3p9Rub9j3JBsYUH5xVdlXQJHuYjfau5YZFXg86KCr3wCm7g8edspRazgnZDzsAnB-1a_z71ecAwisLyLM074nQKwp_pEsMNz8mk3xs_D9imhAIzYHcES4VJZWwAlaVxaGIAF4ZHTjoRqSBRAc9VklqRKzBjAH2swyry1vJcWw1bIZfRBWkUZeEuCVVRYqTSFjqNMIFL48jgH2xzHZjYuCZhW2FmS8-UkW1DyOaZF36Gws-88JukixL_GYs813UHaD_baD_7S_tX__GRa3KI8_JBKjekAcpxtwA1VvquXlVwHX71vgGSMdRU |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=From+colorless+to+pink%3A+Structural+insights+into+vitamin+B12-induced+color+change+in+monoclonal+antibodies&rft.jtitle=Medicine+in+drug+discovery&rft.au=He%2C+Kai-feng&rft.au=Cui%2C+Hao-dong&rft.au=Deng%2C+Wen-hui&rft.au=Xing%2C+Na&rft.date=2025-12-01&rft.issn=2590-0986&rft.eissn=2590-0986&rft.volume=28&rft.spage=100224&rft_id=info:doi/10.1016%2Fj.medidd.2025.100224&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_medidd_2025_100224 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2590-0986&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2590-0986&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2590-0986&client=summon |